Company intelligence / Profile preview
FemmePharma
- Ownership
- Private
- Development stage
- Commercial
Overview
FemmePharma develops both over-the-counter and prescription products focused on women's intimate health. Their commercialized line includes FDA-cleared personal lubricants/moisturizers and supplements for sleep. The company has also conducted numerous clinical trials targeting high unmet needs such as vaginal dryness, menopausal symptoms, overactive bladder, pelvic/reproductive disorders, and breast conditions. They emphasize science-based solutions with doctor approval but do not publish detailed trial results publicly.
- Therapeutic areas
- Women's Health
- Modalities
- Over-the-counter (OTC) productsPrescription therapeuticsSupplements (e.g., sleep aids)
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on FemmePharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FemmePharma.